302 related articles for article (PubMed ID: 16728277)
1. Myeloid precursors and acute myeloid leukemia cells express multiple CD33-related Siglecs.
Nguyen DH; Ball ED; Varki A
Exp Hematol; 2006 Jun; 34(6):728-35. PubMed ID: 16728277
[TBL] [Abstract][Full Text] [Related]
2. Analysis of the CD33-related siglec family reveals that Siglec-9 is an endocytic receptor expressed on subsets of acute myeloid leukemia cells and absent from normal hematopoietic progenitors.
Biedermann B; Gil D; Bowen DT; Crocker PR
Leuk Res; 2007 Feb; 31(2):211-20. PubMed ID: 16828866
[TBL] [Abstract][Full Text] [Related]
3. Therapy of human T-cell acute lymphoblastic leukaemia with a combination of anti-CD7 and anti-CD38-SAPORIN immunotoxins is significantly better than therapy with each individual immunotoxin.
Flavell DJ; Boehm DA; Noss A; Warnes SL; Flavell SU
Br J Cancer; 2001 Feb; 84(4):571-8. PubMed ID: 11207056
[TBL] [Abstract][Full Text] [Related]
4. Humanized M195 monoclonal antibody conjugated to recombinant gelonin: an anti-CD33 immunotoxin with antileukemic activity.
Pagliaro LC; Liu B; Munker R; Andreeff M; Freireich EJ; Scheinberg DA; Rosenblum MG
Clin Cancer Res; 1998 Aug; 4(8):1971-6. PubMed ID: 9717827
[TBL] [Abstract][Full Text] [Related]
5. Expression of the target receptor CD33 in CD34+/CD38-/CD123+ AML stem cells.
Hauswirth AW; Florian S; Printz D; Sotlar K; Krauth MT; Fritsch G; Schernthaner GH; Wacheck V; Selzer E; Sperr WR; Valent P
Eur J Clin Invest; 2007 Jan; 37(1):73-82. PubMed ID: 17181570
[TBL] [Abstract][Full Text] [Related]
6. Monocyte-mediated lysis of acute myeloid leukemia cells in the presence of the bispecific antibody 251 x 22 (anti-CD33 x anti-CD64).
Chen J; Zhou JH; Ball ED
Clin Cancer Res; 1995 Nov; 1(11):1319-25. PubMed ID: 9815927
[TBL] [Abstract][Full Text] [Related]
7. Expression of alpha IIb beta 3 integrin (GPIIb-IIIa) in myeloid cell lines and normal CD34+/CD33+ bone marrow cells.
Wall CD; Conley PB; Armendariz-Borunda J; Sudarshan C; Wagner JE; Raghow R; Jennings LK
Blood Cells Mol Dis; 1997 Dec; 23(3):361-76. PubMed ID: 9398537
[TBL] [Abstract][Full Text] [Related]
8. Negative regulation of leucocyte functions by CD33-related siglecs.
Avril T; Attrill H; Zhang J; Raper A; Crocker PR
Biochem Soc Trans; 2006 Dec; 34(Pt 6):1024-7. PubMed ID: 17073742
[TBL] [Abstract][Full Text] [Related]
9. C-type lectin-like molecule-1: a novel myeloid cell surface marker associated with acute myeloid leukemia.
Bakker AB; van den Oudenrijn S; Bakker AQ; Feller N; van Meijer M; Bia JA; Jongeneelen MA; Visser TJ; Bijl N; Geuijen CA; Marissen WE; Radosevic K; Throsby M; Schuurhuis GJ; Ossenkoppele GJ; de Kruif J; Goudsmit J; Kruisbeek AM
Cancer Res; 2004 Nov; 64(22):8443-50. PubMed ID: 15548716
[TBL] [Abstract][Full Text] [Related]
10. A study of CD33 (SIGLEC-3) antigen expression and function on activated human T and NK cells: two isoforms of CD33 are generated by alternative splicing.
Hernández-Caselles T; Martínez-Esparza M; Pérez-Oliva AB; Quintanilla-Cecconi AM; García-Alonso A; Alvarez-López DM; García-Peñarrubia P
J Leukoc Biol; 2006 Jan; 79(1):46-58. PubMed ID: 16380601
[TBL] [Abstract][Full Text] [Related]
11. Delivery of saporin to human B-cell lymphoma using bispecific antibody: targeting via CD22 but not CD19, CD37, or immunoglobulin results in efficient killing.
Bonardi MA; French RR; Amlot P; Gromo G; Modena D; Glennie MJ
Cancer Res; 1993 Jul; 53(13):3015-21. PubMed ID: 7686448
[TBL] [Abstract][Full Text] [Related]
12. Molecular characterization, tissue expression, and mapping of a novel Siglec-like gene (SLG2) with three splice variants.
Yousef GM; Ordon MH; Foussias G; Diamandis EP
Biochem Biophys Res Commun; 2001 Jun; 284(4):900-10. PubMed ID: 11409878
[TBL] [Abstract][Full Text] [Related]
13. Primitive AML progenitors from most CD34(+) patients lack CD33 expression but progenitors from many CD34(-) AML patients express CD33.
Vercauteren S; Zapf R; Sutherland H
Cytotherapy; 2007; 9(2):194-204. PubMed ID: 17453971
[TBL] [Abstract][Full Text] [Related]
14. Cloning and molecular characterization of two splice variants of a new putative member of the Siglec-3-like subgroup of Siglecs.
Foussias G; Taylor SM; Yousef GM; Tropak MB; Ordon MH; Diamandis EP
Biochem Biophys Res Commun; 2001 Jun; 284(4):887-99. PubMed ID: 11409877
[TBL] [Abstract][Full Text] [Related]
15. In vitro bone marrow purging of multidrug-resistant cells with a mouse monoclonal antibody directed against Mr 170,000 glycoprotein and a saporin-conjugated anti-mouse antibody.
Dinota A; Tazzari PL; Michieli M; Visani G; Gobbi M; Bontadini A; Tassi C; Fanin R; Damiani D; Grandi M
Cancer Res; 1990 Jul; 50(14):4291-4. PubMed ID: 1694719
[TBL] [Abstract][Full Text] [Related]
16. Antibody-targeted therapy for myeloid leukemia.
Appelbaum FR
Semin Hematol; 1999 Oct; 36(4 Suppl 6):2-8. PubMed ID: 10530710
[TBL] [Abstract][Full Text] [Related]
17. Expression of CD33-related siglecs on human mononuclear phagocytes, monocyte-derived dendritic cells and plasmacytoid dendritic cells.
Lock K; Zhang J; Lu J; Lee SH; Crocker PR
Immunobiology; 2004; 209(1-2):199-207. PubMed ID: 15481154
[TBL] [Abstract][Full Text] [Related]
18. Membrane CD22 defines circulating myeloma-related cells as mature or later B cells.
Perfetti V; Vignarelli MC; Bellotti V; Glennie MJ; Zorzoli I; Ubbiali P; Obici L; Massa M; Ippoliti G; Ascari E; Merlini G
Lab Invest; 1997 Oct; 77(4):333-44. PubMed ID: 9354768
[TBL] [Abstract][Full Text] [Related]
19. Anti-CD33 monoclonal antibodies enhance the cytotoxic effects of cytosine arabinoside and idarubicin on acute myeloid leukemia cells through similarities in their signaling pathways.
Balaian L; Ball ED
Exp Hematol; 2005 Feb; 33(2):199-211. PubMed ID: 15676214
[TBL] [Abstract][Full Text] [Related]
20. Selective apoptotic killing of malignant hemopoietic cells by antibody-targeted delivery of an amphipathic peptide.
Marks AJ; Cooper MS; Anderson RJ; Orchard KH; Hale G; North JM; Ganeshaguru K; Steele AJ; Mehta AB; Lowdell MW; Wickremasinghe RG
Cancer Res; 2005 Mar; 65(6):2373-7. PubMed ID: 15781652
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
